Article Text

AB0480 Towards A Novel Tolerogenic Dendritic Cell Based Immunotherapy for Systemic Lupus Erythematosus
  1. F.A. Vega1,2,
  2. A. Torres1,
  3. S. Iacobelli1,
  4. A. Kalergis2,
  5. C. Llanos1
  1. 1Millennium Institute on Immunology and Immunotherapy, Departamento de Reumatología e Inmunología Clínica, Escuela de Medicina
  2. 2Millennium Institute on Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biolόgicas, Pontificia Universidad Catόlica de Chile, Santiago, Chile


Background Tolerogenic dendritic cells (tolDCs) can be considered as an attractive strategy to treat autoimmune diseases. The tolerogenic potential of autologous tolDCs has not yet been evaluated to treat systemic lupus erythematosus (SLE). Although the specific autoantigens involved in the pathogenesis of SLE are still unknown, a failure in the clearance of apoptotic debris seems to be associated with the onset of disease.

Objectives To evaluate in vitro the regulatory function and phenotype stability of tolDCs generated from peripheral blood monocytes of SLE patients and to assess whether apoptotic cells affect the tolerogenic function of tolDCs.

Methods Peripheral blood mononuclear cells were collected from SLE patients and healthy controls and seeded on cell culture plates, non-adherent cells were thoroughly washed out. Monocytes were differentiated into dendritic cells (DCs) by addition of GM-CSF and IL-4 every other day in AIM-V medium for 5 days. tolDCs were generated by addition of rosiglitazone (RGZ) and/or dexametasone (DEXA) for 24 hours. Tolerogenic phenotype stability was evaluated by challenging tolDCs with lipopolysaccharide (LPS) for 48 hours. Autologous apoptotic T cells were generated by exposure to UV-B radiation (1–1,5 mW/cm2 for 90 minutes) then stained with CFSE for tracking and feeded to tolDCs for 24 hours. Capture of apoptotic cells by tolDCs was assessed by flow cytometry and confocal microscopy. Costimulatory molecules of DCs were evaluated by flow cytometry.

Results At the end of the differentiation process, DCs from SLE patients and healthy controls showed a CD11c+ HLA-DR+ CD14 DC phenotype. Induction of maturation leads to increase of maturation markers such as CD83 and PD-L1. tolDCs generated from SLE patients with RGZ and/or DEXA showed a reduced expression of maturation markers after stimulation with LPS for 48 hours in comparison to mature DCs. tolDCs pulsed with CFSE-stained autologous apoptotic T cells displayed positive staining for CFSE by flow cytometry, suggesting internalization of apoptotic cells by tolDCs. This result was confirmed by confocal microscopy. The phenotype of RGZ-tolDCs from SLE patients showed no difference when treated with autologous apoptotic cells.

Conclusions We were able to generate DCs from SLE monocytes with a stable immature/tolerogenic phenotype. These cells are capable of capturing apoptotic cells without changing their phenotype, which may provide a suitable source for the autoantigens involved in the SLE onset.


  1. Kuhn A, Wenzel J, Weyd H. Photosensitivity, Apoptosis, and Cytokines in the Pathogenesis of Lupus Erythematosus: a Critical Review. Clinical reviews in allergy & immunology. Jan 14 2014.

  2. Llanos C, Mackern-Oberti JP, Vega F, Jacobelli SH, Kalergis AM. Tolerogenic dendritic cells as a therapy for treating lupus.ClinImmunol. Aug 2013;148(2):237-245.

  3. Kalergis AM, Iruretagoyena MI, Barrientos MJ, et al. Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus. Immunology. Sep 2009;128(1 Suppl):e306-314.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.3976

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.